Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
SHR
Neuro
Krebs
Kardio
Stoffw
Microb
Lipid
GENINCA - Genomic instability and genomic alterations in pre-cancerous lesions and/or cancer
- Abstract
- GENINCA will address two tumor entities, for which we have good access to pre-malignant lesions and in which genomic instability is a common feature: colorectal and liver cancer.
GENINCA represents a collaborative study of 8 academic and 3 industrial partners from 5 European countries. GENINCA will focus on exploring pre-cancerous and cancer lesions of the two aforementioned tumor entities and their respective microenvironment. As the recent identification of human colon-cancer initiating cells by one of our academic consortium members paves the way for completely new strategies for studying mechanisms of tumorgenesis, a particular focus of this grant proposal will be the detailed characterization of these cancer initiating stem cells. At present, it is still a matter of debate which genomic changes are already present in precursor lesions and whether these lesions already show genetic instability. We will therefore address the occurrence of genomic instability and explore their underlying mechanisms especially in pre-cancerous and early cancer lesions. This will be greatly facilitated by in vivo endomicroscopy approaches, sophisticated animal models and large-scale genomic and proteomic analyses. Furthermore, we ill include an in-depth analysis of the corresponding microenvironment. As this represents a translational research effort, we expect to identify markers for novel therapeutic and/or preventative strategies, as well as facilitating tumor diagnosis, prognosis, and monitoring.
- Projektleitung:
- Speicher Michael
- Laufzeit:
- 01.01.2008-30.06.2011
- Programm:
- EU (FP-7)
- Subprogramm
- HEALTH-2007-2.4.1-3
- EU-Projektinstrument
- Collaborative Project (Small or Medium-Scale focused research Project)
- Art der Forschung
- Angewandte Forschung
- Mitarbeiter*innen
- Speicher, Michael, Projektleiter*in
- Beteiligte MUG-Organisationseinheiten
- Diagnostik und Forschungsinstitut für Humangenetik
- Projektpartner
- Biolution Grünert & co keg, Österreich
- Cancer Research UK, Großbritannien
- Cordeliers Research Center, Frankreich
- IFOM Foundation - The FIRC Institute of Molecular Oncology Foundation, Italien
- Institut National de Sante et Recherche Medicale, Frankreich
- Instituto Superiore di Sanità, Italien
- Medizinische Universität Hannover, Deutschland
- Mosaiques Diagnostics & Therapeutics AG, Deutschland
- Oridis Biomed, Forschungs- und Entwicklungs-GmbH, Österreich
- Universität Ulm, Deutschland
- Universitätsklinikum Hamburg-Eppendorf, Deutschland
- University of Mainz, Deutschland
- Gefördert durch
- Europäische Kommission, Rue de la Loi, Brussels, Belgien